enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time ...

   www.aol.com/glp-1-drugs-no-longer-101500620.html

   Another GLP-1 drug, Trulicity, which is also used to treat type 2 diabetes, was its third-best-selling drug, but saw its sales fall 31% to $1.25 billion as patients shifted to its newer GLP-1 ...

3. GLP-1 questions emerge for 2025 - AOL

   www.aol.com/finance/glp-1-questions-emerge-2025...

   The 2025 outlook for GLP-1s isn't as bullish as it once was, but all hope is not lost. ... Click here for in-depth analysis of the latest health industry news and events impacting stock prices ...

4. GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy? - AOL

   www.aol.com/glp-1-drugs-drive-growth-093000472.html

   Given the popularity of GLP-1 drugs and the potential for an oral GLP-1 drug launch in 2026, Lilly remains very well positioned. As such, I think the stock still looks attractive at current levels.

5. Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is ...

   www.aol.com/eli-lilly-shares-fall-glp-111700194.html

   The good news for investors is that for 2025, overall guidance is looking strong. Lilly is projecting between $58 billion and $61 billion in sales, which is mostly higher than the $58.4 billion ...

6. Novo Nordisk 'comfortable' with impact of Medicare price ...

   www.aol.com/finance/novo-nordisk-comfortable...

   The two longer-term headwinds facing GLP-1 drugs — Medicare negotiations going into effect in 2027 and the patent cliff for semaglutide in 2032 — are why the company has already started ...

7. Novo Nordisk CEO grilled by Senate committee over GLP-1 prices

   www.aol.com/finance/novo-nordisk-ceo-grilled...

   The drugs, known as GLP-1s, have brought in $50 billion in revenue for Novo Nordisk year to date alone, but the high prices ($1,349 for Wegovy and $968 for Ozempic) have put them out of reach for ...

8. Amgen's peek at its GLP-1 drug trial results heightens ... - AOL

   www.aol.com/finance/amgens-peek-glp-1-drug...

   Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...

9. Largest-ever Ozempic and GLP-1 drug study finds they lower ...

   www.aol.com/finance/largest-ever-ozempic-glp-1...

   According to a KFF analysis, the list price for GLP-1 drugs can range between $936 and $1,349 before insurance, manufacturer coupons or rebates. As the GLP-1 patients in Al-Aly’s study were all ...